Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
Not Applicable
Completed
- Conditions
- Hepatocellular CarcinomaBile Duct CancerPancreatic CancerColorectal CarcinomaLiver MetastasesPrimary Liver CancerGallbladder Cancer
- Registration Number
- NCT01640522
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.
- Detailed Description
The study is a collaborative care intervention designed to reduce pain, fatigue, and depressive symptoms and improve overall health related quality of life.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 261
Inclusion Criteria
- biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma
- age 18 years or older
- fluency in English. Exclusion criteria included:
Exclusion Criteria
- current suicidal or homicidal ideation
- current psychosis or thought disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Depression Change from baseline at 6 and 12 months Center for Epidemiological Studies-Depression scale
- Secondary Outcome Measures
Name Time Method Fatigue Change from baseline at 6 and 12 months Functional Assessment of Cancer Therapy-Fatigue
Trial Locations
- Locations (1)
University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center🇺🇸Pittsburgh, Pennsylvania, United States